Swiss patient treated with Varian's Gated RapidArc technology
Radiotherapy provider Varian Medical Systems has treated its first patient with its Gated RapidArc system, a radiotherapy treatment technology that monitors patient breathing and compensates for tumor motion.
The 51-year-old breast cancer patient was treated at the Istituto Oncologico della Svizzera Italiana radiation oncology unit in Bellinzona, Switzerland, in approximately four minutes, stated Palo Alto, Calif.-based Varian.
The technology, which is now a standard feature on the TrueBeam system and is available as an option or upgrade on the Trilogy and Clinac iX accelerators from Varian, will be used to treat all left-sided breast cancer patients when there is a need to include the supraclavicolar or internal mammary chain lymph nodes, as well as lung and other thoracic and abdominal cancer patients at the Swiss facility, the company said.
The 51-year-old breast cancer patient was treated at the Istituto Oncologico della Svizzera Italiana radiation oncology unit in Bellinzona, Switzerland, in approximately four minutes, stated Palo Alto, Calif.-based Varian.
The technology, which is now a standard feature on the TrueBeam system and is available as an option or upgrade on the Trilogy and Clinac iX accelerators from Varian, will be used to treat all left-sided breast cancer patients when there is a need to include the supraclavicolar or internal mammary chain lymph nodes, as well as lung and other thoracic and abdominal cancer patients at the Swiss facility, the company said.